Assessment of ONS-flavour Preference in Cancer Patients With and Without Taste Alterations

Inclusion criteria

• Being diagnosed with cancer
• Undergoing, or having undergone systemic anti-cancer treatment or radiotherapy in the past 12 months.
• Age > 18 years
• Written informed consent

Exclusion criteria

• Taste and smell alterations not caused by the cancer or anti-cancer treatment
• Galactosaemia
• Use of thickener to be able to swallow safely
• Allergies to any of the product ingredients or any of the flavours
• Current prescription for ONS, enteral nutrition or parenteral nutrition
• Diabetes mellitus Type I or Type II
• Open sores or severe inflammation in the mouth or throat
• Undergoing dialysis
• Hepatic encephalopathy
• Patients with heart failure who have symptoms of heart failure at rest and/or are unable to carry on any physical activity without discomfort
• Known pregnancy or lactation
• Average alcohol use of > 21 glasses per week for men or > 14 glasses per week for women or drug abuse in opinion of the investigator
• Investigator's uncertainty about the willingness or ability of the subject to comply with the protocol requirements
• Participation in any other studies involving food products concomitantly or within two weeks prior to entry into the study.
• Employees of Nutricia Research and/or partners, parents, children and brothers/sisters of employees